Background Current HIV-1 envelope glycoprotein (Env) vaccines are unable to induce cross-reactive neutralizing antibodies. coincided with CrNA development. These included a statistically shorter variable region 1 and a lower probability of glycosylation as implied by a high ratio of NXS NXT glycosylation motifs. Furthermore lesser probability of glycosylation at position 332 which is usually involved… Continue reading Background Current HIV-1 envelope glycoprotein (Env) vaccines are unable to induce